Sex‐Related Differences in Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.123.032553 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Mohamad S Alabdaljabar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine Mayo Clinic Rochester MN. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Ethanol, Ablation Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Previous studies have shown that women with hypertrophic obstructive cardiomyopathy (HCM) have worse long‐term outcomes irrespective of intervention. However, the outcomes of patients undergoing alcohol septal ablation (ASA) based on sex have not been described. Hence, this study aimed to evaluate pressure changes and long‐term mortality in patients with HCM undergoing ASA based on sex. Methods and Results This is a single‐center retrospective study evaluating hemodynamic changes and long‐term mortality in patients with HCM treated with ASA according to sex. A total of 259 patients were included (aged 68.4±11.9 years, 62.2% women). Women had higher age and baseline pressures at the time of ASA, with a greater percent reduction in mean left atrial pressure (men versus women: 2.2% versus 15.9%, respectively; P =0.02). Women had better survival (median survival rate of men versus women: 8.6 versus 12.5 years, respectively; P =0.011). On Cox multivariable regression, predictors of mortality were age (per group change 80 years; hazard ratio [HR], 1.45 [95% CI, 1.10–1.91], P =0.008), female sex (HR, 0.59 [95% CI, 0.35–0.99], P =0.048), chronic kidney disease (HR, 1.88 [95% CI, 1.06–3.33], P =0.031), and left ventricular outflow tract gradient reduction ≤86% (HR, 1.91 [95% CI, 1.14–3.19], P =0.014).
Conclusions
Women with HCM undergoing ASA are older and have higher left‐sided baseline pressures compared with men yet have better survival. Further studies exploring the mechanisms of differential outcomes according to sex in patients with HCM undergoing ASA are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine Mayo Clinic Rochester MN.
- Department of Cardiovascular Medicine Mayo Clinic Rochester MN.
ORCID-Profile: Mohamad S Alabdaljabar, Mohamed Elhadi, Jeffrey B Geske, Kyle W Klarich, Mayra Guerrero, Mackram F Eleid
Zitieren
APA
Alabdaljabar, M. S., Elhadi, M., Geske, J. B., Klarich, K. W., Guerrero, M., & Eleid, M. F. (2024). Sex‐Related Differences in Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.032553
Vancouver
Alabdaljabar MS, Elhadi M, Geske JB, Klarich KW, Guerrero M, Eleid MF. Sex‐Related Differences in Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.032553
BibTeX
@article{Alabdaljabar2024,
author = {Alabdaljabar, Mohamad S and Elhadi, Mohamed and Geske, Jeffrey B and Klarich, Kyle W and Guerrero, Mayra and Eleid, Mackram F},
title = {Sex‐Related Differences in Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.123.032553}
}
EUVIMED